GOAL 1 To provide clinicians and public health officials with the - - PowerPoint PPT Presentation

goal 1
SMART_READER_LITE
LIVE PREVIEW

GOAL 1 To provide clinicians and public health officials with the - - PowerPoint PPT Presentation

GOAL 1 To provide clinicians and public health officials with the following information related to ricin: Background Clinical Presentation Recognition and Diagnosis Personal Protective Equipment Decontamination


slide-1
SLIDE 1

GOAL 1

  • Background
  • Clinical Presentation
  • Recognition and Diagnosis
  • Personal Protective Equipment
  • Decontamination
  • Management
  • Reporting

To provide clinicians and public health officials with the following information related to ricin:

slide-2
SLIDE 2

GOAL 2

  • To provide clinicians and public health
  • fficials with information on

epidemiological clues that may suggest illness associated with ricin or another chemical or biological toxin in the correct clinical context.

slide-3
SLIDE 3

Objectives

  • Describe the epidemiology of

nonterrorism-associated ricin poisoning

  • Describe the epidemiology of terrorism-

associated ricin poisoning

slide-4
SLIDE 4

Objectives

  • Describe the clinical manifestations of
  • ral, inhalational, and parenteral ricin

poisoning

  • Describe differential diagnosis for ricin

poisoning

slide-5
SLIDE 5

Objectives

  • Explain the diagnosis of ricin poisoning
  • Identify epidemiological clues

suggestive of a possible covert ricin (or

  • ther chemical/biological toxin) release
  • Describe the clinical management of

ricin poisoning

slide-6
SLIDE 6

Objectives

  • Describe the disposition of patients with

ricin-associated illness

  • Identify the proper authorities for

reporting of suspected or known ricin- associated illness

slide-7
SLIDE 7

CDC/ATSDR Training and Continuing Education Online System

www.phppo.cdc.gov/phtnonline

slide-8
SLIDE 8

Caster Bean Photos

slide-9
SLIDE 9

Ricinus Communis

slide-10
SLIDE 10

Castor Beans

slide-11
SLIDE 11

Ricin Characteristics

  • Ricin can be prepared in a liquid,

crystalline, or dry powder form

  • Ricin is water soluble, odorless,

tasteless, and stable under ambient conditions

slide-12
SLIDE 12

Mechanism of Action and Toxicity of Ricin

slide-13
SLIDE 13

Biological Toxalbumins

  • Abrus precatorius (contains abrin)
  • Ricinus communis (contains ricin)
  • Robinia pseudoacacia (contains robin
  • and phasin)
  • Hura crepitans
  • Jatropha curcas
  • Jatropha gossypifolia
slide-14
SLIDE 14

Category B Diseases/Agents

  • are moderately easy to disseminate;
  • result in moderate morbidity rates and

low mortality rates; and

  • require specific enhancements of CDC's

diagnostic capacity and enhanced disease surveillance.

Second highest priority agents include those that

slide-15
SLIDE 15

Other Category B Bioterrorism Agents

  • Brucellosis
  • Glanders
  • Q Fever
  • Typhus Fever
  • Psittacosis
  • Staphylococcal Enterotoxin B
slide-16
SLIDE 16

Ricin Exposure

  • Inhalation and intravenous injection are

the most lethal routes

  • Ricin is not well absorbed orally or

dermally

slide-17
SLIDE 17

Oral Administration

  • The absorption of orally administered

ricin is poor, but if enough ricin is ingested, the potential for significant morbidity and mortality exists.

slide-18
SLIDE 18

Ricin Absorbtion

  • Not likely to be absorbed through

unabraded skin; however, there are no reported studies on the dermal toxicity

  • f ricin
  • The effect of adding a carrier solvent to

ricin to increase dermal absorption is unknown

slide-19
SLIDE 19

Nonterroism Ricin Poisoning

  • Over 400 cases of poisoning by

ingestion

  • 14 deaths (12 prior to 1930)
slide-20
SLIDE 20

Ricin: Aerosol Exposure

slide-21
SLIDE 21

Ricin: Parenteral Exposure

slide-22
SLIDE 22

Ricin as a Chemotherapeutic Agent

slide-23
SLIDE 23

Ricin and Terrorism

  • Properties make it a potential terrorist

agent

  • Would need to be aerosolized, added to

food, beverage or consumer products

slide-24
SLIDE 24

Ricin and Terrorism

Georgi Markov

500 micrograms of ricin was injected

slide-25
SLIDE 25

Ricin and Terrorism

  • 1991- Unsuccessful dermal attack plan

to kill 100 people

  • 1995-Agents find 130 grams of ricin at

Canadian border, enough to kill 10,000 people.

slide-26
SLIDE 26

Ricin and Terrorism

slide-27
SLIDE 27

Ricin and Terrorism

  • December 2002, six terrorist suspects

were arrested in Manchester, England

  • January 2003, subtoxic quantities of

ricin were found in the Paris Metro, leading to an investigation of a plan to attack the Russian embassy

slide-28
SLIDE 28

Osama bin Ladin

slide-29
SLIDE 29

Clinical Manifestation

slide-30
SLIDE 30

Route of Exposure

  • Inhalation
  • Ingestion
  • Parenteral
slide-31
SLIDE 31

Aerosol Dispersion

  • Not considered persistent in the

environment

  • Particles under 5 microns may stay

suspended for many hours

  • Re-suspension of settled ricin may
  • ccur
  • Technologically difficult to produce

particles of this small size

slide-32
SLIDE 32

Systemic Toxicity

  • Severe systemic toxicity has been

described in humans only following ingestion or injection of ricin into the body

slide-33
SLIDE 33

Ricin Ingestion

  • Ricin release from beans requires

mastication

  • Swallowing whole beans not likely to

poison

  • Beans have bitter taste
  • No reports of people who have ingested

purified ricin

slide-34
SLIDE 34

Ricin Fatal Dose

  • Ingestion and mastication of 3-6 beans

is the estimated fatal dose in adults (presumed less in children)

slide-35
SLIDE 35

Ricin: Mild Toxicity Symptoms

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal cramping
  • Oropharyngeal irritation

Symptoms of mild toxicity include:

slide-36
SLIDE 36

Onset of Gastrointestinal Symptoms

  • Typically occurs in less than 10 hours.
  • Delayed presentation of gastrointestinal

symptoms, beyond ten hours of ingestion, is unlikely to occur.

slide-37
SLIDE 37

Moderate to Severe Toxicity

  • Gastrointestinal symptoms persistent

vomiting, voluminous diarrhea-bloody or non- bloody (which typically leads to significant fluid losses)

  • Dehydration, hypovolemic shock,

tachycardia, hypotension, decreased urine

  • utput, altered mental status (e.g., confusion,

disorientation).

May Include: May Result In:

slide-38
SLIDE 38

Severe Poisoning

  • Hepatic and renal failure and death are

possible within 36 – 72 hours of exposure

slide-39
SLIDE 39

Ricin Inhalation

  • Very limited data in humans
  • Animal studies suggest it is the most

lethal form of exposure.

slide-40
SLIDE 40

Ricin Allergic Syndrome

  • Nasal and throat congestion
  • Eye irritation
  • Hives and other skin irritation
  • Chest tightness
  • Wheezing (severe cases)
slide-41
SLIDE 41

1940’s : An Unintentional and Sublethal Aerosol Exposure

  • Fever
  • Chest tightness
  • Cough
  • Dyspnea
  • Nausea
  • Arthralgias
  • Diaphoresis
  • No reported progression
slide-42
SLIDE 42

Progression

  • Pulmonary edema and hemorrhage
  • Hypotension
  • Respiratory failure
  • Death within 36-72 hours
slide-43
SLIDE 43

Parenteral Exposure

slide-44
SLIDE 44

Clinical Trial

  • Flu-like symptoms
  • Fatique
  • Myalgias
  • Symptoms lasting 1-2 days
slide-45
SLIDE 45

Lethal Injection (Markov-1978)

  • Immediate pain
  • Weakness within 5 hours
  • Fever
  • Vomiting
  • Shock
  • Multi-organ failure
  • Death in 3 days
slide-46
SLIDE 46

Lethal Injection Example 2

  • Nausea
  • Weakness
  • Dizziness
  • Myalgias
  • Anuria
  • Hypotension
  • Hepatorenal and cardiorespiratory failure
  • Death
slide-47
SLIDE 47

Ricin: Clinical Course

slide-48
SLIDE 48

Significant ricin poisoning through inhalation, ingestion and parenteral exposure would consist of progressive worsening

  • f symptoms over approximately

4-36 hours.

slide-49
SLIDE 49

Early Ricin poisoning through ingestion may resemble typical gastroenteritis-type or a respiratory illness through inhalation

slide-50
SLIDE 50

May be difficult to discern early poisoning from other common and less virulent illnesses such as an upper respiratory infection

  • r gastroenteritis.
slide-51
SLIDE 51

Cases should be deemed suspicious in conjunction with

  • A highly suspected or known exposure
  • A credible threat
  • An epidemiologic clue suggestive of a

chemical release.

slide-52
SLIDE 52

Differential Diagnosis

slide-53
SLIDE 53

Inhalation:

  • Staphylococcal enterotoxin B
  • Exposure to pyrolysis by-products of
  • rganofluorines (Teflon, Kevlar)
  • Oxides of nitrogen
  • Phosgene
  • Influenza
  • Anthrax
  • Q-fever
  • Pneumonic plague
slide-54
SLIDE 54

Ingestion:

  • Enteric pathogens (e.g., salmonella,

shigella)

  • Mushrooms
  • Caustics
  • Iron
  • Arsenic
  • Colchicine
slide-55
SLIDE 55

Clinical Diagnosis

slide-56
SLIDE 56

Overt Event

  • Letter identifying ricin in contents of

package

  • Restaurant patrons unknowingly

consume food contaminated with ricin

Covert Event

slide-57
SLIDE 57

Illness Resulting from Covert Event

  • Symptoms similar to flu or

gastroenteritis

  • Early symptoms may be nonexistent or

mild

  • Reports of illness may occur over a long

period and in multiple locations

slide-58
SLIDE 58

Illness Resulting from Covert Event

  • Symptoms may not suggest a single

chemical

  • Healthcare providers may be less

familiar with clinical presentations of chemical or biological-induced poisonings

slide-59
SLIDE 59

Epidemiologic Clues Suggesting Covert Release of a Chemical or Biological toxin

  • Unusual increase in patients with possible

chemical or biological toxin related illness

  • Unexplained deaths among healthy or young

people

  • Unexplained odors on patients
  • Clusters of illness in people with common

characteristics

slide-60
SLIDE 60

Epidemiologic Clues Suggesting Covert Release of a chemical or biological toxin

  • Rapid onset of symptoms
  • Unexplained death of plants, fish, or

animals

  • Presence of a particular syndrome

associated with a chemical agent or biological toxin

slide-61
SLIDE 61
  • Clinical diagnosis largely depends on

route of exposure

  • Clinical findings associated with ricin

poisoning may be nonspecific and may mimic signs and symptoms of less virulent diseases

slide-62
SLIDE 62

Confirmation of Ricin Poisoning

  • Clinical manifestations of illness
  • Laboratory detection of ricin in biological

fluids or environmental samples

slide-63
SLIDE 63

Laboratory Testing

  • No validated assays for detection of

ricin in biologic fluids

  • Testing of environmental samples may

not be immediately available to assist in clinical decision making

slide-64
SLIDE 64

Suspicion and clinical diagnosis

  • f ricin poisoning should occur

when clinically compatible illness is present in conjunction with:

  • A highly suspected or known exposure,
  • A credible threat, OR
  • An applicable epidemiologic clue
slide-65
SLIDE 65

Decontamination and Personal Protective Equipment

slide-66
SLIDE 66

Patient Contaminated with Ricin

  • Provide gross decontamination at the

scene unless medical condition dictates immediate transport to hospital

slide-67
SLIDE 67

Gross Decontamination

  • Cut away/remove all suspected

contaminated clothing

  • Remove jewelry and watches
  • Wash off obvious contamination with

soap and copious amount of water

  • Shower with liquid soap and warm

water

slide-68
SLIDE 68

Gross Decontamination

  • Provide privacy
  • Secure personal belongings
  • Explain procedure to victims
slide-69
SLIDE 69

Decontamination

  • Clean environmental surfaces or

equipment with soap and water or 0.1% sodium hypochlorite solution

  • Double bag, label and secure victims’

clothing

slide-70
SLIDE 70

Decontamination of Nondisposable PPE

  • Thoroughly rinse with soap and water
  • Soak in 0.1% sodium hypochlorite

solution for 15 minutes

  • Rinse with water and air dry
slide-71
SLIDE 71

PPE for First Responders

  • Determined by incident commander
  • Based on hazard assessment and site

conditions

  • PPE should prevent droplets from

contacting broken skin or mucosal membranes

slide-72
SLIDE 72

PPE if Victims Inadequately Decontaminated at Scene

  • Chemical-resistant suit with gloves
  • Surgical mask
  • Eye/face protection
slide-73
SLIDE 73

Decontamination

  • Should be done at scene or hospital but

prior to entering emergency department

  • Removing contaminated clothing

reduces contaminant 75%-90%

slide-74
SLIDE 74

Standard Precautions

  • Scrubs or disposable gown
  • Lab coat
  • Disposable nitrile gloves
  • Surgical mask
  • Safety glasses, goggles, or face shield
  • Good hand hygiene
slide-75
SLIDE 75

Clinical Management

slide-76
SLIDE 76

Primary Management

  • Supportive
  • No antidote
  • Dialysis ineffective
slide-77
SLIDE 77

Standard Precautions

  • After skin decontamination
  • With patient’s belongings
  • With patient’s secretions

Continue use:

slide-78
SLIDE 78

Ricin Ingestion

  • Patient presents <1 hour after exposure
  • No vomiting
  • No contraindications

Consider gastric lavage if

If ricin powder ingested, may consider nasogastric tube

slide-79
SLIDE 79

Ricin Ingestion

  • If no vomiting and airway is secure, give

a single dose of activated charcoal

slide-80
SLIDE 80

Ricin Ingestion

  • Administer intravenous fluids
  • Provide blood pressure support using

intravenous vasopressors

  • Consider alternative diagnoses and

treat appropriately (e.g., antibiotics for possible infection)

slide-81
SLIDE 81

Inhalational and Parenteral Poisoning

  • Supplemental oxygen
  • Pulmonary toilet
  • Mechanical ventilation
  • May require hemodialysis
slide-82
SLIDE 82

National Poison Control Center Hotline

1-800-222-1222

slide-83
SLIDE 83

Disposition

  • Is there a highly suspected or known

exposure?

  • Is there a credible threat?
  • Is there an applicable epidemiologic

clue to suggest an illness potentially related to a chemical or biological toxin?

slide-84
SLIDE 84

Disposition

  • Treat and admit patients with clinical

findings consistent with ricin poisoning plus

– A highly suspected or known exposure

OR

– Presentation occurs with a credible threat

slide-85
SLIDE 85

Disposition

  • Due to limited experience with ricin

poisoning, a definitive period of

  • bservation cannot be specified at this

time

slide-86
SLIDE 86

Disposition

  • Asymptomatic patients exposed to

highly suspected or known ricin- containing compound should be

  • bserved for symptoms
  • Instruct patients sent home to return to

hospital immediately if symptoms consistent with ricin poisoning develop

slide-87
SLIDE 87

Contact the regional poison control center and the local and/or state public health agency in all cases of illness consistent with ricin poisoning in the presence of:

  • A suspected or known exposure
  • A credible threat OR
  • An applicable epidemiologic clue
slide-88
SLIDE 88

National Poison Control Center Hotline

1-800-222-1222

slide-89
SLIDE 89

Public Health Surveillance and Reporting

slide-90
SLIDE 90

Contact the regional poison control center and the local and/or state public health agency in all cases of illness consistent with ricin poisoning in the presence of:

  • A suspected or known exposure,
  • A credible threat, OR
  • An applicable epidemiologic clue
slide-91
SLIDE 91

E-mail questions to: ricinquestions@cdc.gov

slide-92
SLIDE 92

Course Overview

www.phppo.cdc.gov/phtn/ricin

slide-93
SLIDE 93

CDC Ricin Website

www.bt.cdc.gov/agent/ricin

slide-94
SLIDE 94

Public Health Foundation

Phone: 1-877-252-1200 Fax: 301-843-0159 Online: bookstore.phf.org

slide-95
SLIDE 95

CDC Training and Continuing Education Online System www.phppo.cdc.gov/phtnonline

slide-96
SLIDE 96

Course Numbers

WC0048 - webcast WD0035 - web-on -demand CB3093 - CD-ROM

slide-97
SLIDE 97

Registration Questions: 800-41-TRAIN 404-639-1292 E-mail ce@cdc.gov